dr. luke on ongoing studies with immunotherapy in melanoma
Published 7 years ago • 91 plays • Length 1:10Download video MP4
Download video MP3
Similar videos
-
2:05
dr. luke on challenges with immunotherapy in melanoma
-
1:51
dr. luke on immunotherapy diagnostics in melanoma
-
1:12
dr. luke on future research with t-cell therapy in melanoma
-
1:20
dr. luke on immunotherapy advancements in melanoma
-
1:06
dr. luke on the future role of immunotherapy combinations in melanoma
-
1:30
dr. jason luke discusses nivolumab and pembrolizumab in melanoma
-
4:32
overall toxicities with immunotherapy in melanoma
-
1:30
dr. jason luke on sequencing targeted and immunotherapy agents in braf melanoma
-
38:01
melanoma immunotherapy with dr. jedd wolchok
-
20:21
new immune therapy for melanoma – how to know which treatment protocol will work for a patient?
-
31:44
melanoma & immunotherapy: ask dr. michael atkins
-
1:48
dr. luke on current and emerging treatment approaches in metastatic melanoma
-
1:03
dr. weber on risk and benefits with immunotherapy combos in melanoma
-
1:10
dr. luke on adjuvant therapies in development for melanoma
-
1:20:31
choosing innovation with immunotherapy in melanoma
-
1:41
dr. luke discusses combination approaches on horizon in melanoma
-
0:59
dr. luke on treatment options in metastatic melanoma
-
0:43
keynote-716: adjuvant pembrolizumab for high-risk melanoma
-
1:15
dr. hamid on tmb as a biomarker for immunotherapy response in melanoma
-
1:01
dr. luke on the future of combination therapy in melanoma
-
1:50
nuances of immunotherapy-related aes in melanoma
-
47:41
treating melanoma with immunotherapy, with jedd wolchok